MX362677B - Farmaco a base de curcumina para el tratamiento de infeccion parasitaria provocada por la giardia lamblia. - Google Patents

Farmaco a base de curcumina para el tratamiento de infeccion parasitaria provocada por la giardia lamblia.

Info

Publication number
MX362677B
MX362677B MX2009000683A MX2009000683A MX362677B MX 362677 B MX362677 B MX 362677B MX 2009000683 A MX2009000683 A MX 2009000683A MX 2009000683 A MX2009000683 A MX 2009000683A MX 362677 B MX362677 B MX 362677B
Authority
MX
Mexico
Prior art keywords
treatment
parasitic infection
curcumin
infection caused
giardia lamblia
Prior art date
Application number
MX2009000683A
Other languages
English (en)
Other versions
MX2009000683A (es
Inventor
Alberto Ramirez Herrera Mario
Luisa Mendoza Magaña Maria
Cortes Zarate Rafael
Original Assignee
Univ Guadalajara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Guadalajara filed Critical Univ Guadalajara
Publication of MX2009000683A publication Critical patent/MX2009000683A/es
Publication of MX362677B publication Critical patent/MX362677B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición farmacéutica preparada a base de curcumina para el tratamiento de una infección parasitaria, específicamente aquella causada por la giardia lamblia, cuyos efectos citotóxicos sobre el parásito inhiben su capacidad de crecimiento y de adhesión, y además induce alteraciones morfológicas y efectos similares a la apoptosis en dicho parásito. La nueva composición formulada a base del derivado de una planta es una alternativa viable y altamente eficaz para el tratamiento de giardiosis que se caracteriza porque, a diferencia de otros fármacos utilizados para tratar el mismo padecimiento, no provoca efectos secundarios que induzcan al paciente a la suspensión del tratamiento.
MX2009000683A 2006-07-19 2006-07-19 Farmaco a base de curcumina para el tratamiento de infeccion parasitaria provocada por la giardia lamblia. MX362677B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000073 WO2008010697A1 (es) 2006-07-19 2006-07-19 Fármaco a base de curcumina para el tratamiento de infección parasitaria provocada por la giardia lamblia

Publications (2)

Publication Number Publication Date
MX2009000683A MX2009000683A (es) 2009-09-21
MX362677B true MX362677B (es) 2018-09-26

Family

ID=38956993

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009000683A MX362677B (es) 2006-07-19 2006-07-19 Farmaco a base de curcumina para el tratamiento de infeccion parasitaria provocada por la giardia lamblia.

Country Status (3)

Country Link
BR (1) BRPI0621872A2 (es)
MX (1) MX362677B (es)
WO (1) WO2008010697A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
ES2121539B1 (es) * 1996-07-25 1999-05-16 Invest De La Ind Agroalimentar Procedimiento para la obtencion de un colorante alimentario estable a base de curcumina.
ES2154610B1 (es) * 1999-09-23 2001-11-16 Asac Compania De Biotecnologia Nuevas actividades farmacologicas de los extractos de curcuma longa.
WO2005077393A1 (en) * 2004-01-19 2005-08-25 Ranbaxy Laboratories Limited Herbal formulation comprising extracts of adhatoda, hedychium and curcuma as cough syrup

Also Published As

Publication number Publication date
BRPI0621872A2 (pt) 2012-10-16
WO2008010697A1 (es) 2008-01-24
MX2009000683A (es) 2009-09-21

Similar Documents

Publication Publication Date Title
MX2012007410A (es) Compuestos antivirales novedosos.
AU2011338389A8 (en) Bicyclic compounds as Pim inhibitors
JO3265B1 (ar) مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
BR112012018386A8 (pt) "inibidores isoindolinona de fosfatidilinositol 3-quinase"
AR077277A1 (es) Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
MX2010013766A (es) Rasagilina para modificacion de enfermedad de parkinson.
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MX2011008448A (es) Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia.
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
EA025086B9 (ru) Производные индоламида и родственные соединения для использования при лечении нейродегенеративных заболеваний
MX354423B (es) Formulaciones de rasagilina de liberación prolongada y usos de las mismas.
MX2013011086A (es) (aralquilamino y heteroarilalquilamino alfa-sustituidos)pirimidini lo y 1,3,5-triazinilbenzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para su uso en el tratamiento de enfermedades proliferativas.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
EA201290516A1 (ru) Гетероароматические производные соединения фенилимидазола в качестве ингибиторов фермента pde10a
EE05761B1 (et) Kombineeritud ravimkoostis diabeedi ning ainevahetushäirete raviks
MX2010009270A (es) Compuestos y metodos para la prevencion o tratamiento de reestenosis.
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
CO6410283A2 (es) Métodos para administrar (4ar,10ar)-1-n-propil-1,2,3,4,4a,5,10,10a-octahidro-benzo[g]quinolin-6,7-diol y compuestos relacionados a través de la mucosa oral, la mucosa nasal o la piel, y sus compoisiciones farmacéuticas
EP2438923A4 (en) COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF OBSERVATION-BASED ILLNESSES BY THE ACTIVATION OF AMPK AND WITH 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURANLIGNANES AS ACTIVE SUBSTANCES
EP4282414A3 (en) Modified release tablet formulations containing phosphodiesterase inhibitors
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
UA109414C2 (uk) Арильовані камфени та фармацевтична композиція на їх основі
PL2244703T3 (pl) Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii
EA201071209A1 (ru) Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для регуляции уровня калия в крови
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors

Legal Events

Date Code Title Description
FG Grant or registration